In Vitro Antiviral Activity of Nordihydroguaiaretic Acid against SARS-CoV-2
Viruses · 2023-05-11 · 15 (5) · 1155
DOI: 10.3390/v15051155 ↗At a glance
Journal article in Viruses, published online on 2023-05-11. Written by Erendira Villalobos-Sánchez and 6 co-authors. Institution: Medical and Pharmaceutical Biotechnology Unit, Center of Research and Assistance in Technology and Design of the State of Jalisco, Guadalajara 44270,…. Major MEDLINE topics: SARS-CoV-2, COVID-19. Cited 8 times so far (Crossref); 48 references. The full text is freely available (open access, CC BY 4.0). Funded by: CONACYT.
Abstract (original language)
The coronavirus infectious disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has been spreading rapidly worldwide, creating a pandemic. This article describes the evaluation of the antiviral activity of nordihydroguaiaretic acid (NDGA), a molecule found in Creosote bush (Larrea tridentata) leaves, against SARS-CoV-2 in vitro. A 35 µM concentration of NDGA was not toxic to Vero cells and exhibited a remarkable inhibitory effect on the SARS-CoV-2 cytopathic effect, viral plaque formation, RNA replication, and expression of the SARS-CoV-2 spike glycoprotein. The 50% effective concentration for NDGA was as low as 16.97 µM. Our results show that NDGA could be a promising therapeutic candidate against SARS-CoV-2.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Medical and Pharmaceutical Biotechnology Unit, Center of Research and Assistance in Technology and Design of the State of Jalisco, Guadalajara 44270, Mexico.
- CONACYT, Medical and Pharmaceutical Biotechnology Unit, Center of Research and Assistance in Technology and Design of the State of Jalisco, Guadalajara 44270, Mexico.
- Coordinación de Calidad de Insumos y Laboratorios Especializados, Instituto Mexicano del Seguros Social, México City 27170, Mexico.
ORCID profiles: Erendira Villalobos-Sánchez, Tanya A Camacho-Villegas, Alejandro A Canales-Aguirre, Abel Gutiérrez-Ortega, José E Muñoz-Medina, Darwin E Elizondo-Quiroga
Funding
- CONACYT
Cite
APA
Villalobos-Sánchez, E., García-Ruiz, D., Camacho-Villegas, T. A., Canales-Aguirre, A. A., Gutiérrez-Ortega, A., Muñoz-Medina, J. E., & Elizondo-Quiroga, D. E. (2023). In Vitro Antiviral Activity of Nordihydroguaiaretic Acid against SARS-CoV-2. Viruses, 15(5), 1155. https://doi.org/10.3390/v15051155
Vancouver
Villalobos-Sánchez E, García-Ruiz D, Camacho-Villegas TA, Canales-Aguirre AA, Gutiérrez-Ortega A, Muñoz-Medina JE, et al. In Vitro Antiviral Activity of Nordihydroguaiaretic Acid against SARS-CoV-2. Viruses. 2023;15(5):1155. doi:10.3390/v15051155
BibTeX
@article{VillalobosSnchez2023,
author = {Villalobos-Sánchez, Erendira and García-Ruiz, Daniel and Camacho-Villegas, Tanya A and Canales-Aguirre, Alejandro A and Gutiérrez-Ortega, Abel and Muñoz-Medina, José E and Elizondo-Quiroga, Darwin E},
title = {In Vitro Antiviral Activity of Nordihydroguaiaretic Acid against SARS-CoV-2},
journal = {Viruses},
year = {2023},
volume = {15},
number = {5},
pages = {1155},
doi = {10.3390/v15051155}
}
EUVIMED